MEDIA

Grifols and the Public Investment Fund of Saudi Arabia to boost plasma medicines self-supply in the region

February 13, 2020

Grifols PharmacyKeeper ranked No. 1 in KLAS rating, extends category leadership

January 16, 2020

Grifols to launch TAVLESSE^® in Europe and Turkey to continue reinforcing its commercial strategy and commitment to patients

Show more news

Media contacts

Journalist or media professional?

Our Media Relations team is available at:
(+34) 93 571 00 02
media@grifols.com.
Restricted to media inquiries only.

Not a journalist?

For general questions and requests, please contact corporatecomms@grifols.com.

AMBAR

AMBAR in the Media

Press releases about AMBAR clinical trial and media coverage.

Content: footer-organization-info

The information contained on the Grifols worldwide website is not applicable to all countries. For specific information on the products and services available in your country, please select your country from the list included in the corresponding section. The purpose of this website is to provide information about Grifols' products and services, and it is not intended for, nor may it be construed to, promoting any products in countries in which they are not approved.

INVESTORS